The Fetal Bovine Serum Market is being driven by Rising adoption of stem cell applications
The Fetal Bovine Serum Market is expected to grow at a CAGR of 6.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 364.2 million. The Fetal Bovine Serum (FBS) market has experienced significant growth due to the increasing demand for new pharmaceutical products in response to the global rise in chronic diseases. FBS plays a crucial role in cell-based research and development, particularly in cell culture testing for pharmaceuticals. This serum surpasses standard cell culture requirements, enhancing the growth medium for various applications such as biotechnology research, vaccine manufacturing, cloning, and in vitro fertilization. Its versatility and effectiveness make it an indispensable component in cell-based screening and profiling technologies.
Get more information on Fetal Bovine Serum Market by requesting a sample report
The market is segmented based on segments_for_ai.nslist
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
210 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.1% |
Market growth 2025-2029 |
USD 364.2 million |
Market structure |
Fragmented |
YoY growth 2024-2025(%) |
5.4 |
Key countries |
US, Germany, China, UK, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Fetal Bovine Serum (FBS) market encompasses various sectors including cell line development, biotechnology patents, software, and tools. Ethical considerations in biotechnology, market challenges, and bioprocessing are key aspects. Cell proliferation, clinical trials, gene therapy, and regenerative medicine are application areas. Biomanufacturing, biotech startups, education, and regulations also play a role. Biotech conferences, books, databases, and investment opportunities provide knowledge and funding. Biosimilar development, innovation, and gene editing technology advancements are shaping the industry. Agricultural sustainability and global food security are intersecting areas, with FBS used in animal agriculture for growth promotion and inhibition, disease modeling, and human vaccine production. Animal welfare, beef prices, cell expansion, synthetic biology, and animal agriculture ethics are additional considerations.
The Fetal Bovine Serum (FBS) market is a significant segment of the larger life science tools and services industry. This market caters to the demand for FBS in embryo culture and cell growth applications, primarily used in research and development (R&D) settings. FDA-approved animal serum, such as FBS, plays a crucial role in providing essential nutrients for biologics production and drug discovery processes in contract research organizations (CROs). The global life science tools and services market, which encompasses manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and related services, is expected to grow substantially due to the increasing need for advanced research solutions and an aging population, leading to a higher prevalence of diseases requiring diagnostic and therapeutic interventions.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted